Whitelogolarge.jpg
The M&A Class Action Firm Continues Investigating the Merger – VIVO, AERI, CYBE, GMTX
September 22, 2022 12:57 ET | Monteverde & Associates PC
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
BES_Mark.jpg
MERIDIAN BIOSCIENCE ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of VIVO and Encourages Investors to Contact the Firm
July 11, 2022 16:06 ET | Bragar Eagel & Squire
NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
VIVO LOSS ALERT: Rosen Law Firm Reminds Meridian Bioscience, Inc. Investors of Important Deadline in Class Action – VIVO
December 26, 2017 09:05 ET | The Rosen Law Firm PA
NEW YORK, Dec. 26, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meridian Bioscience, Inc. (NASDAQ:VIVO) from March 25, 2016...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Meridian Bioscience, Inc. – VIVO
December 12, 2017 17:11 ET | The Rosen Law Firm PA
NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Meridian...
MBI_Logo_Tagline_Blue.jpg
New Testing Procedure Holds Promise As a Critical Tool in the Global Effort to Eliminate Malaria
April 24, 2017 03:30 ET | Meridian Bioscience, Inc.
CINCINNATI, April 24, 2017 (GLOBE NEWSWIRE) -- As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a...
MBI_Logo_Tagline_Blue.jpg
ECCMID Presentation to Demonstrate Revolutionary Breakthrough in Malaria Detection
April 17, 2017 05:30 ET | Meridian Bioscience, Inc.
VIENNA, Austria, April 17, 2017 (GLOBE NEWSWIRE) -- Leading malaria researcher Tom van Gool’s presentation at the 27th European Congress for Clinical Microbiology and Infectious Diseases (ECCMID)...